Replies to post #72846 on Biotech Values

[DewDiligence]

IDIX – Today’s 8K filing merely covers the rudiments of the deal with little detail beyond what’s in the PR. The juicy additional details that rkrw asked for will be in IDIX’s 10K, which is due later this month. From today’s 8-K filing:

The foregoing summary description of the License Agreement is not complete and is qualified in its entirety by reference to the License Agreement, which the Company expects to file as an exhibit to its Annual Report on Form 10-K for the year ended December 31, 2008.